Impact BioMedical to begin efficacy testing of pan-coronavirus vaccine under new wholly owned subsidiary Innate Immune, Inc. ... Oct 05
SGX-listed Singapore eDevelopment Ltd's (SeD; SGX:40V) wholly owned subsidiary Impact Biomedical Inc., announced recently that their suite of antiviral and medical technologies, ... Apr 26
-Advertisements-